Connect Biopharma Holdings
CNTB
16 hedge funds and large institutions have $372M invested in Connect Biopharma Holdings in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 13 closing their positions.
181% more capital inflows, than outflows
Capital inflows: $92.1M | Capital outflows: $32.8M
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
6.4% more ownership
Funds ownership: 26.77% → 33.18% (+6.4%)
38% less funds holding
Funds holding: 26 → 16 (-10)
77% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA Capital Management
Boston,
Massachusetts
|
+$66.7M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$12.4M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$10.2M |
| 4 |
Old Well Partners
Charlotte,
North Carolina
|
+$2.04M |
| 5 |
Millennium Management
New York
|
+$530K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Farallon Capital Management
San Francisco,
California
|
-$7.4M |
| 2 |
Cormorant Asset Management
Boston,
Massachusetts
|
-$5.84M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$3.58M |
| 4 |
Logos Global Management
San Francisco,
California
|
-$2.78M |
| 5 |
Rock Springs Capital Management
Baltimore,
Maryland
|
-$2.2M |
CNTB Hedge Fund Activity: Q2 2021 in Review
16 of the 5,769 institutional investors tracked by Wall St. Rank reported a position in Connect Biopharma Holdings (CNTB) for Q2 2021, worth a combined $372M — up 31% from $285M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of CNTB and 3 opened new positions — a net loss of 10 holders — while 4 trimmed existing stakes and 5 added.
The largest buyer was RA Capital Management, adding an estimated $66.7M. The largest seller was Farallon Capital Management, exiting entirely with an estimated $7.4M sold.
- 16 institutional investors held Connect Biopharma Holdings (CNTB) as of Q2 2021, down from 26 in Q1 2021.
- Funds reported $372M of Connect Biopharma Holdings stock for Q2 2021, up 31% quarter-over-quarter.
- 3 funds opened new Connect Biopharma Holdings positions in Q2 2021 and 13 closed out, a net change of -10 holders.
- The largest Connect Biopharma Holdings buyer in Q2 2021 was RA Capital Management, an estimated $66.7M added.
- The largest Connect Biopharma Holdings seller in Q2 2021 was Farallon Capital Management, an estimated $7.4M sold.
Based on aggregated 13F filings for Q2 2021.